Back to Search Start Over

PGE 2 expression by HPV6/11-induced respiratory papillomas blocks NK cell activation in patients with recurrent respiratory papillomatosis.

Authors :
Israr M
Lam F
DeVoti J
Mace EM
Papayannakos C
Abramson A
Steinberg BM
Bonagura VR
Source :
European journal of immunology [Eur J Immunol] 2023 Apr; Vol. 53 (4), pp. e2250036. Date of Electronic Publication: 2023 Jan 31.
Publication Year :
2023

Abstract

Recurrent respiratory papillomatosis (RRP), a rare chronic disease caused primarily by human papillomavirus types 6 and 11, consists of repeated growth of premalignant papillomas in the airway. RRP is characterized by multiple abnormalities in innate and adaptive immunity. Natural killer (NK) cells play important roles in immune surveillance and are part of the innate immune responses that help prevent tumor growth. We identified that papillomas lack classical class I MHC and retain nonclassical class I MHC expression. Moreover, in this study, we have identified and characterized the mechanism that blocks NK cell targeting of papilloma cells. Here, we show for the first time that the PGE <subscript>2</subscript> secreted by papilloma cells directly inhibits NK cells activation/degranulation principally through the PGE <subscript>2</subscript> receptor EP2, and to a lesser extent through EP4 signaling. Thus, papilloma cells have a potent mechanism to block NK cell function that likely supports papilloma cell growth.<br /> (© 2023 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.)

Details

Language :
English
ISSN :
1521-4141
Volume :
53
Issue :
4
Database :
MEDLINE
Journal :
European journal of immunology
Publication Type :
Academic Journal
Accession number :
36608264
Full Text :
https://doi.org/10.1002/eji.202250036